Tai Roun Products Co.,Ltd. AI Stock Analysis
Tai Roun Products Co.,Ltd. (1220) AI Stock Analysis
Tai Roun Products Co.,Ltd.
(TWSE:1220)
The score is driven primarily by weak financial performance, especially declining profitability and negative free cash flow. Bearish technical trends and an exceptionally high P/E ratio provide additional downside pressure, partially offset by the company's low leverage.
Tai Roun Products Co.,Ltd. (1220) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 1.74B
- Dividend Yield
- 2.03%
- Average Volume (3M)
- 108.19K
- Price to Earnings (P/E)
- 154.7
- Beta (1Y)
- 0.27
- Revenue Growth
- -5.47%
- EPS Growth
- -79.97%
- Country
- TW
- Employees
- 246
- Sector
- General
- Sector Strength
- 55
- Industry
- Packaged Foods
Tai Roun Products Co.,Ltd. Business Overview & Revenue Model
Company Description
Tai Roun Products Co., Ltd. operates within Taiwan, primarily focusing on the manufacturing and distribution of animal feed. Their extensive product line caters to a diverse range of livestock and aquatic species, including swine, poultry (chickens,...
Tai Roun Products Co.,Ltd. Financial Statement Overview
Summary
Financial performance is weak overall: declining revenue and sharply compressed margins, negative free cash flow, and deteriorating cash generation outweigh the conservatively leveraged balance sheet.
Income Statement
28NegativeBalance Sheet
72PositiveCash Flow
18Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.28B | 3.33B | 3.48B | 3.29B | 3.54B | 3.22B |
| Gross Profit | 329.45M | 320.53M | 557.72M | 438.09M | 308.99M | 467.13M |
| EBITDA | 136.78M | 124.39M | 387.80M | 286.86M | 169.30M | 319.61M |
| Net Income | 12.16M | 13.53M | 207.41M | 133.27M | 45.88M | 177.91M |
Balance Sheet | ||||||
| Total Assets | 3.48B | 3.53B | 3.48B | 3.20B | 3.20B | 3.29B |
| Cash, Cash Equivalents and Short-Term Investments | 476.83M | 424.60M | 529.76M | 393.38M | 235.74M | 462.45M |
| Total Debt | 577.78M | 507.51M | 317.38M | 294.87M | 330.50M | 157.75M |
| Total Liabilities | 991.87M | 968.75M | 811.77M | 661.89M | 768.89M | 698.08M |
| Stockholders Equity | 2.28B | 2.34B | 2.45B | 2.32B | 2.22B | 2.36B |
Cash Flow | ||||||
| Free Cash Flow | -296.78M | -58.34M | 76.04M | 346.65M | -215.07M | 62.35M |
| Operating Cash Flow | -194.46M | 48.91M | 177.60M | 394.46M | -103.42M | 265.39M |
| Investing Cash Flow | -70.63M | -147.44M | -94.62M | -52.73M | -94.59M | -199.24M |
| Financing Cash Flow | 235.69M | -9.91M | -10.00M | -161.49M | -63.55M | -117.51M |
Tai Roun Products Co.,Ltd. Peers Comparison
Overall Rating
TW:491172Outperform
TW:696866Neutral
TW:129559Neutral
TW:122040Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | TWD 1.74B | 18.66 | ― | 4.66% | -26.73% | -34.96% | |
| 66Neutral | TWD 1.92B | 14.79 | ― | 3.42% | 14.75% | 11.14% | |
| 59Neutral | TWD 1.58B | 10.17 | ― | 7.14% | -5.28% | -27.33% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 40Underperform | TWD 1.79B | 154.70 | ― | 2.03% | -5.47% | -79.97% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1220 | Tai Roun Products Co.,Ltd. | 9.87 | -2.66 | -21.20% | |
| TW:1295 | Synbio Tech Inc | 41.90 | -52.13 | -55.44% | |
| TW:4911 | G&E Herbal Biotechnology Co., Ltd. | 25.00 | -18.60 | -42.66% | |
| TW:6808 | 3D Global Biotech Inc. | 26.10 | -19.30 | -42.51% | |
| TW:6968 | Wonder Pets Enterprises Corp. | 38.00 | -15.85 | -29.43% | |
| TW:7705 | Mercuries F&B Co Ltd | 28.20 | -10.76 | -27.61% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
